Literature DB >> 16724236

Efficacy and safety of nasal desmopressin in the long-term treatment of primary nocturnal enuresis.

Kenichi Kano, Osamu Arisaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16724236     DOI： 10.1007/s00467-006-0137-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  4 in total

1.  Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Swedish Enuresis Trial Group.

Authors:  K Tullus; R Bergström; I Fosdal; I Winnergård; K Hjälmås
Journal:  Acta Paediatr       Date:  1999-11       Impact factor: 2.299

2.  Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.

Authors:  Tack Lee; Hong Jin Suh; Hun Jae Lee; Ji Eun Lee
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

3.  Comparing alarms, desmopressin, and combined treatment in Chinese enuretic children.

Authors:  Cherry Fai-Ngo Ng; Sik-Nin Wong
Journal:  Pediatr Nephrol       Date:  2004-12-17       Impact factor: 3.714

4.  Primary nocturnal enuresis: a comparison among observation, imipramine, desmopressin acetate and bed-wetting alarm systems.

Authors:  J M Monda; D A Husmann
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.